News

GM maggots against wound infections

New Zealand scientists have proposed genetically modifying carrion green flies and using their larvae to accelerate wound healing.

Sexual arousal: the main thing is to direct potassium ions in the right direction

When norepinephrine is exposed to ventromedial hypothalamic neurons, the general arousal of the animal contributes to the emergence of sexual arousal, which in turn forms a special behavior, without which reproduction is impossible.

Estonian calf with human growth hormone gene

When the calf becomes an adult cow, it will be able to give milk saturated with growth hormone, which can then be isolated and used in the pharmaceutical industry.

Lost weight to death

According to various sources, about 2,000 people died due to taking a weight loss product containing amphetamines.

Sunflower seeds against prostate cancer metastases

Practice brain surgery in a 3D simulator

The peculiarity of the SRP simulator is the visualization of the patient's anatomy according to CT and MRI data. During the virtual operation, doctors will see a realistic image of surgical instruments and the reaction of the patient's tissues to the actions of the doctor.

Either Roche stole, or Roche was stolen…

Despite the investigation being conducted against Roche, none of its drugs are being withdrawn from the market and no restrictions are imposed on their use, since there is no confirmed evidence of the negative consequences of taking them.

The first three Centers of Science, Innovation and Education in Skoltech

These centers, where work will be carried out in the field of biomedicine and energy, will consolidate his reputation as a leader in the relevant areas of scientific research.

Ultrasound treatment of testes – the future of male contraception

Ultrasound treatment of the testes reduces the number of spermatozoa in the ejaculate of male mice to indicators corresponding to the diagnosis of infertility in humans.

Innovative medicines: from America to Russia

RUSNANO's Board of Directors approved a project to create a diversified production of innovative medicines in Russia with the participation of the American venture fund Domain Associates LLC.

We sell Israeli companies "turnkey"

Cukierman Investment Company & Co Investment house is creating a fund for Israeli companies entering the Russian market in the field of high technologies and biotechnologies.

Motherhood changes the brain for the better

uru and transferring them to an insoluble state.

Embryonic stem cells returned state funding

The District Court of Appeals in Washington overturned a previous lower court decision prohibiting state funding of stem cell research.

Let's sing our genome!

On July 13, the New London Chamber Choir will perform the musical work "Allele" in the building of the Royal Medical Society, in which excerpts from the genomes of each of the 40 singers will be performed.

Do not leave a fortune-teller (who does not pay taxes) alive

One of the initiators of the bill pointed out that a significant amount of advertising of magicians, psychics and other persons who cause moral and physical harm to citizens is presented in the media. Due to the imperfection of legislation, fraudsters and charlatans act openly and with impunity.

IV Olympiad in Nanotechnology: distribution of prizes

The closing ceremony and awarding of the winners of the IV All-Russian Internet Olympiad in Nanotechnology took place in the Assembly Hall of the Fundamental Library of Moscow State University.

Vitamin C against premature aging

Vitamin C stops and even reverses the process of premature aging in mice with a model of Werner syndrome (adult progeria).

Crisis and biotechnology: we are dying, but we are not giving up!

By the end of 2008, 162 public biotech companies (44% of the total) had less than a year's worth of cash. A year earlier, this figure was 25%.

Healthy life in Russia

In terms of healthy life expectancy, Russia is noticeably ahead of, among others, the Netherlands, Finland and Austria.

The third phase

Clinical trials of a cocktail of two antibodies with the working name REGN-COV2 have entered the final stage.